Aspen Pharmacare (South Africa) Performance
| APN Stock | 17,378 831.00 5.02% |
The firm shows a Beta (market volatility) of -0.0063, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Aspen Pharmacare are expected to decrease at a much lower rate. During the bear market, Aspen Pharmacare is likely to outperform the market. At this point, Aspen Pharmacare Holdings has a negative expected return of -0.14%. Please make sure to confirm Aspen Pharmacare's treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if Aspen Pharmacare Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aspen Pharmacare Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
| Begin Period Cash Flow | 6 B | |
| Total Cashflows From Investing Activities | -2.2 B |
Aspen |
Aspen Pharmacare Relative Risk vs. Return Landscape
If you would invest 1,915,800 in Aspen Pharmacare Holdings on September 23, 2024 and sell it today you would lose (178,000) from holding Aspen Pharmacare Holdings or give up 9.29% of portfolio value over 90 days. Aspen Pharmacare Holdings is generating negative expected returns and assumes 1.2679% volatility on return distribution over the 90 days horizon. Simply put, 11% of stocks are less volatile than Aspen, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Aspen Pharmacare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspen Pharmacare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aspen Pharmacare Holdings, and traders can use it to determine the average amount a Aspen Pharmacare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1139
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | APN |
Estimated Market Risk
| 1.27 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aspen Pharmacare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aspen Pharmacare by adding Aspen Pharmacare to a well-diversified portfolio.
Aspen Pharmacare Fundamentals Growth
Aspen Stock prices reflect investors' perceptions of the future prospects and financial health of Aspen Pharmacare, and Aspen Pharmacare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aspen Stock performance.
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 78.78 B | |||
| Shares Outstanding | 444.95 M | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 1.60 X | |||
| Revenue | 38.61 B | |||
| EBITDA | 10.61 B | |||
| Total Debt | 105 M | |||
| Book Value Per Share | 159.44 X | |||
| Cash Flow From Operations | 5.37 B | |||
| Earnings Per Share | 14.32 X | |||
| Total Asset | 111.38 B | |||
About Aspen Pharmacare Performance
By analyzing Aspen Pharmacare's fundamental ratios, stakeholders can gain valuable insights into Aspen Pharmacare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aspen Pharmacare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aspen Pharmacare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Aspen Pharmacare Holdings performance evaluation
Checking the ongoing alerts about Aspen Pharmacare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aspen Pharmacare Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aspen Pharmacare generated a negative expected return over the last 90 days | |
| About 61.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Aspen Pharmacare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aspen Pharmacare's stock is overvalued or undervalued compared to its peers.
- Examining Aspen Pharmacare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aspen Pharmacare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aspen Pharmacare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aspen Pharmacare's stock. These opinions can provide insight into Aspen Pharmacare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aspen Stock analysis
When running Aspen Pharmacare's price analysis, check to measure Aspen Pharmacare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspen Pharmacare is operating at the current time. Most of Aspen Pharmacare's value examination focuses on studying past and present price action to predict the probability of Aspen Pharmacare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspen Pharmacare's price. Additionally, you may evaluate how the addition of Aspen Pharmacare to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |